LFSCvsARKGETF Comparison
VS
F/m Emerald Life Sciences Innovation ETF (LFSC) belongs to the Life Sciences segment. ARK Genomic Revolution ETF (ARKG) is part of the BioTech & Genomics segment. LFSC's top 3 sector exposures are Healthcare and Sovereign. In contrast, ARKG's top sector exposures are Healthcare LFSC is more expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.75% for ARKG. LFSC is up 23.23% year-to-date (YTD) with +$8M in YTD flows. ARKG performs better with 29.47% YTD performance, and +$39M in YTD flows. Run a side-by-side ETF comparison of LFSC and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
LFSC vs ARKG performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | LFSC ARKG | +4.17%-1.87% | +20.39%+27.92% | +23.23%+29.47% | +82.30%+45.31% | n/a+4.16% | n/a-54.66% |
| Flows | LFSC ARKG | +$2M+$81M | +$3M+$62M | +$8M+$39M | +$17M-$3M | --$550M | --$2.57B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | LFSC ARKG | +26.23%+44.86% | +26.91%+42.64% | n/a+43.40% | n/a+45.98% |
| Max drawdown | LFSC ARKG | -6.53%-13.14% | -16.25%-27.52% | n/a-51.67% | n/a-79.29% |
| Max drawdown duration | LFSC ARKG | 20d18d | 168d126d | n/a1058d | n/a1814d |
Trading data
LFSC | ARKG | |
Last sale 7/27/2026 at 1:30 PM | $45.30 | $37.75 |
| Previous close 07/24/2026 | $45.10 | $37.81 |
| Consolidated volume 07/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 7/27/2026 at 1:30 PM
Live
Closed
LFSC | ARKG | |
|---|---|---|
| Last price | $45.30 | $37.75 |
| 1D performance | +0.44% | -0.16% |
| AuM | $123.48 M | $1.53 B |
| E/R | 0.79% | 0.75% |
Characteristics
LFSC | ARKG | |
|---|---|---|
| Management strategy | Active | Active |
| Provider | Emerald Group | Ark Investment |
| Benchmark | - | - |
| N° of holdings | 40 | 31 |
| Asset class | - | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 31, 2024 | April 2, 2019 |
| ESG | No | No |
Advertisement
Exposure
Countries
LFSC
USA
90.9%
United Kingdom
7.04%
Other
2.06%
ARKG
USA
86.99%
Other
13.01%
Sectors
LFSC
Healthcare
98.03%
Other
1.97%
ARKG
Healthcare
96.93%
Other
3.07%
Advertisement
Diversification
LFSC
Total weight of top 15 holdings out of 15
73.24%
ARKG
Total weight of top 15 holdings out of 15
74.95%
Top 15 holdings
Data as of June 30, 2026
LFSC
Travere Therapeutics, Inc.
8.37%
Cogent Biosciences, Inc.
7.18%
LivaNova Plc
7.04%
Spyre Therapeutics, Inc.
6.71%
Guardant Health, Inc.
5.56%
Corcept Therapeutics, Inc.
5.27%
Mirum Pharmaceuticals, Inc.
5.25%
BillionToOne, Inc.
4.25%
Cytokinetics, Inc.
4.13%
Veradermics, Inc.
3.76%
United Therapeutics Corp.
3.55%
Trevi Therapeutics, Inc.
3.50%
Savara, Inc.
3.20%
Dianthus Therapeutics, Inc.
2.77%
Nektar Therapeutics
2.70%
ARKG
Twist Bioscience Corp.
9.15%
Tempus AI, Inc.
7.64%
Absci Corp.
7.01%
10X Genomics, Inc.
7.00%
CRISPR Therapeutics AG
6.56%
Personalis, Inc.
6.19%
Beam Therapeutics, Inc.
4.34%
Guardant Health, Inc.
4.28%
Natera, Inc.
4.11%
Illumina, Inc.
3.98%
Veracyte, Inc.
3.24%
CareDx, Inc.
3.08%
Recursion Pharmaceuticals, Inc.
2.85%
Eli Lilly & Co.
2.81%
Compass Pathways Plc
2.70%
Frequently asked questions about LFSC and ARKG
How have the LFSC and ARKG ETFs performed in 2026?
As of July 24, 2026, LFSC is up 23.23% year-to-date (YTD), while ARKG has returned 29.47%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: LFSC or ARKG?
Year-to-date, the LFSC ETF saw +$8M in flows, compared to +$39M for ARKG.
Which ETF is more volatile: LFSC or ARKG?
Over the past year, LFSC had a volatility of 26.91%, while ARKG experienced 42.64%.
Which ETF is bigger: LFSC or ARKG?
As of July 24, 2026, LFSC holds $123.48 M in assets under management (AUM), while ARKG manages $1.53 B.
What sectors do the LFSC and ARKG ETFs invest in?
LFSC leans toward sectors like Healthcare. Meanwhile, ARKG focuses on Healthcare.
What are the top holdings of the LFSC ETF and ARKG ETF?
LFSC top holdings include Travere Therapeutics, Inc., Cogent Biosciences, Inc. and LivaNova Plc. ARKG holds in its top three: Twist Bioscience Corp., Tempus AI, Inc. and Absci Corp..
Which ETF is more diversified: LFSC or ARKG?
LFSC holds 40 securities with 73.24% of its assets in the top 15. ARKG has 31 securities and a top 15 weight of 74.95%.
Advertisement
Latest news about LFSC & ARKG
Advertisement
